Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-046688

EVP, Research & CSO sold 1,375 shares at $36.72 ($50,490)

  • EVP, Research & CSO acquired 1,375 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Virgin Herbert · EVP, Research & CSO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-07-13 Exercise or conversion : show line 1 in the form +1,375 $1.53 $2,104 101,075 D
2021-07-13 Sale : show line 2 in the form −1,375 $36.72 $50,490 99,700 D
Open-market sales · 1,375 sh · avg $36.72 · $50,490

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-07-13 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −1,375 288,005 D
Loading xslF345X03/doc4.xml…